pre-seed
Stage
About
GenLumina is developing a light-activated precision oncology platform that enables spatial control of cancer therapies by activating ultra-small cytotoxic payloads at the tumor site using targeted illumination.
Explore GenLumina's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.